Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Quarterly results Appointed director
|
Surface Oncology, Inc. (SURF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9.2% stake in Surface Oncology, Inc. |
01/31/2023 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 4.9% stake in sURFACE ONCOLOGY, Inc. |
08/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2022 |
SC 13G/A
| ELI LILLY & Co reports a 3.5% stake in * Surface Oncology, Inc. |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2022 |
SC 13G/A
| FMR LLC reports a 3.7% stake in SURFACE ONCOLOGY INC |
01/25/2022 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 6.4% stake in sURFACE ONCOLOGY, Inc. |
07/09/2021 |
SC 13G/A
| ARK Investment Management LLC reports a 10.3% stake in Surface Oncology, Inc. |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| EcoR1 Capital, LLC reports a 4.7% stake in Surface Oncology, Inc. |
02/13/2020 |
SC 13G/A
| Lilly Ventures Fund I LLC reports a 12.5% stake in Surface Oncology, Inc. |
02/13/2020 |
SC 13G/A
| New Enterprise Associates 14, L.P. reports a 11.9% stake in Surface Oncology, Inc. |
02/07/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2020 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 16.7% stake in sURFACE ONCOLOGY, Inc. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| FMR LLC reports a 6.1% stake in SURFACE ONCOLOGY INC |
12/20/2018 |
SC 13G/A
| FMR LLC reports a 6.3% stake in SURFACE ONCOLOGY INC |
|
|